Osteoporosis, bone & mineral

Impaired Bone Tissue Quality Associated With Inflammation in HIV-immunological Nonresponders: A Cross-sectional Analysis

J Clin Endocrinol MetabPublished Cross-sectional study

Authors' conclusion

INRs' condition is significantly associated with higher inflammatory levels, which may contribute to a deleterious effect on bone quality as measured by in vivo microindentation. Further studies are needed to confirm these results and to focus on non-AIDS comorbidities in this subgroup of PWH.

Study context

Population
People with HIV on Antiretroviral Treatment (ART), Hospital del Mar, Barcelona, January 2019 to June 2023matched 1:2
Participants
159 people
Exposure
HIV immunological nonresponders vs immune responders
  • Immunological nonresponders (INRs)n = 53
  • Immune response (IRs)n = 106reference
Outcome
Bone quality by in vivo microindentation (bone material strength index)
Methodological detailssingle-centre, matched 1:2 (INRs:IRs) on age, sex, BMI and ART
  • Single-centre
  • Matched 1:2 (INRs:IRs) on age, sex, BMI and ART

Main finding

As reported in the abstract

Bone material strength index

INRs

79

median · IQR 76–87

IRs

86

median · IQR 82–89

P < 0.001

Observational data: associations, not effects.

Further findings

Bone mineral density (BMD)

Similar BMD in INRs and IRs

Inflammation and vitamin D

INRs had increased high-sensitive C-reactive protein with lower 25-(OH)-vitamin D3
Significant negative correlation between inflammation and bone quality, especially in INRs

Predictors of bone quality

INR status a major predictor of decreased bone quality regardless of conventional risk factors (multivariable linear regression)

Original publication

Impaired Bone Tissue Quality Associated With Inflammation in HIV-immunological Nonresponders: A Cross-sectional Analysis. J Clin Endocrinol Metab. Published 11 November 2024. doi:10.1210/clinem/dgae786

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.